适应性抗菌药物耐药、微生物变异体的描述及其与假体周围关节感染的相关性
假体周围关节感染(PJI)是需综合根治方案的疑难并发症,近二十年采用抗菌骨水泥间隔器与肠外抗菌药物治疗的治愈率基本停滞。本文综述与PJI治疗相关的适应性耐药机制,部分机制已知、部分为新发现,旨在告知临床医生这些机制并讨论其对PJI未来治疗的意义。
要点
- PJI近二十年用抗菌骨水泥间隔器和肠外抗菌药物的治愈率基本停滞
- 功能型间隔器用高剂量抗菌药物骨水泥和载抗菌药物硫酸钙珠强调局部高剂量递送以增强根治
- 微生物在抗菌压力增大下产生超出传统耐药基因的适应性耐药机制,部分机制为新发现
核心结论
- 本综述旨在告知临床医生与PJI相关的已知微生物适应性耐药机制,并讨论这些适应性机制对未来PJI治疗的意义。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- PJI是需综合根治方案的疑难并发症,近二十年使用抗菌骨水泥关节间隔器和肠外抗菌药物的治愈率基本停滞。
- 功能型间隔器采用更高剂量抗菌药物负载骨水泥和载抗菌药物硫酸钙珠,强调局部抗菌药物递送以增强根治。
- 随着抗菌压力增加,微生物群已产生超出传统抗菌药物耐药基因的适应性机制,部分机制已知、部分为新发现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periprosthetic joint infection (PJI) is a difficult complication requiring a comprehensive eradication protocol. Cure rates have essentially stalled in the last two decades, using methods of antimicrobial cement joint spacers and parenteral antimicrobial agents. Functional spacers with higher-dose antimicrobial-loaded cement and antimicrobial-loaded calcium sulphate beads have emphasized local antimicrobial delivery on the premise that high-dose local antimicrobial delivery will enhance eradication. However, with increasing antimicrobial pressures, microbiota have responded with adaptive mechanisms beyond traditional antimicrobial resistance genes. In this review we describe adaptive resistance mechanisms that are relevant to the treatment of PJI. Some mechanisms are well known, but others are new. The objective of this review is to inform clinicians of the known adaptive resistance mechanisms of microbes relevant to PJI. We also discuss the implications of these adaptive mechanisms in the future treatment of PJI. Cite this article: Bone Joint J 2022;104-B(5):575-580.
引用
- Hamad C, Chowdhry M, Sindeldecker D, et al. Adaptive antimicrobial resistance, a description of microbial variants, and their relevance to periprosthetic joint infection. Bone Joint J. 2022. PMID: 35491584. doi:10.1302/0301-620X.104B5.BJJ-2021-1759.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。